Weycker, D., Li, X., Kartashov, A., Barron, R., Edelsberg, J., Xu, H., … Lyman, G. H. (2013). Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy. In Blood (Vol. 122, pp. 2962–2962). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.2962.2962

Weycker, Derek, Xiaoyan Li, Alex Kartashov, Rich Barron, John Edelsberg, Hairong Xu, Vincent Girardi, and Gary H. Lyman. “Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy.” In Blood, 122:2962–2962. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.2962.2962.

Weycker D, Li X, Kartashov A, Barron R, Edelsberg J, Xu H, et al. Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy. In: Blood. American Society of Hematology; 2013. p. 2962–2962.

Weycker, Derek, et al. “Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 2962–2962. Crossref, doi:10.1182/blood.v122.21.2962.2962.

Weycker D, Li X, Kartashov A, Barron R, Edelsberg J, Xu H, Girardi V, Lyman GH. Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy. Blood. American Society of Hematology; 2013. p. 2962–2962.